MeroGel Injectable nasal packing may help prevent adhesions and middle turbinate lateralization, a common cause of FESS failure.1-3
MeroGel® Injectable nasal packing is a bioresorbable, space-occupying gel stent used after functional endoscopic sinus surgery (FESS) or nasal trauma. It's composed of cross-linked polymers of hyaluronic acid and administered with a flexible catheter for easier access to nasal cavities.
During the important postoperative period, MeroGel Injectable nasal packing is intended to:
Our bioresorbable nasal packing products use hyaluronic acid, a linear polysaccharide and naturally occurring constituent of the extracellular matrix.
Hyaluronic acid helps keep the surgical site moist, reduce adhesions, and decrease healing time.4 Esterified hyaluronic acid, or HYAFF®, is a patented formula that is used in our MeroGel and MeroPack® nasal packing products.
HYAFF® is a registered trademark of Fidia Advanced Biopolymers.
Musy PY, Kountakis SE. Anatomic findings in patients undergoing revision endoscopic sinus surgery. Am J Otolaryngol. 2004; 25(6):418-422.
Ramadan HH. Surgical causes of failure in endoscopic sinus surgery. Laryngoscope. 1999; 109:27-29.
Kuhn FA, Citardi MJ. Advances in postoperative care following endoscopic sinus surgery. Otolaryngol Clin North Am. 1997; 30(3):479-490.
Berlucchi M, Castelnuovo P, Vincenzi A, Morra B, Pasquini E. Endoscopic outcomes of resorbable nasal packing after functional endoscopic sinus surgery: a multicenter prospective randomized controlled study. Eur Arch Otorhinolaryngol. 2009; 266(6): 839-845.